Does the media refer more to AHCO or CAI?

In the previous week, Caris Life Sciences had 2 more articles in the media than AdaptHealth. MarketBeat recorded 3 mentions for Caris Life Sciences and 1 mentions for AdaptHealth. AdaptHealth's average media sentiment score of 0.67 beat Caris Life Sciences' score of 0.38 indicating that AdaptHealth is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AdaptHealth 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Caris Life Sciences 0 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media favor BLLN or AHCO?

In the previous week, Billiontoone had 5 more articles in the media than AdaptHealth. MarketBeat recorded 6 mentions for Billiontoone and 1 mentions for AdaptHealth. AdaptHealth's average media sentiment score of 0.67 beat Billiontoone's score of -0.18 indicating that AdaptHealth is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Billiontoone 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral AdaptHealth 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Is RDNT or AHCO more profitable?

RadNet has a net margin of -0.66% compared to AdaptHealth's net margin of -2.42%. RadNet's return on equity of 2.77% beat AdaptHealth's return on equity. Company Net Margins Return on Equity Return on Assets RadNet -0.66% 2.77% 0.97% AdaptHealth -2.42% 2.76% 0.99%

Does the media prefer RDNT or AHCO?

In the previous week, RadNet had 6 more articles in the media than AdaptHealth. MarketBeat recorded 7 mentions for RadNet and 1 mentions for AdaptHealth. AdaptHealth's average media sentiment score of 0.67 beat RadNet's score of 0.04 indicating that AdaptHealth is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment RadNet 2 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral AdaptHealth 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Is CELC or AHCO more profitable?

Celcuity has a net margin of 0.00% compared to AdaptHealth's net margin of -2.42%. AdaptHealth's return on equity of 2.76% beat Celcuity's return on equity. Company Net Margins Return on Equity Return on Assets Celcuity N/A -244.61% -50.22% AdaptHealth -2.42% 2.76% 0.99%

Does the media prefer CELC or AHCO?

In the previous week, Celcuity had 4 more articles in the media than AdaptHealth. MarketBeat recorded 5 mentions for Celcuity and 1 mentions for AdaptHealth. Celcuity's average media sentiment score of 1.74 beat AdaptHealth's score of 0.67 indicating that Celcuity is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Celcuity 5 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive AdaptHealth 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

AdaptHealth (AHCO) Competitors

$9.70 +0.04 (+0.41%)

Closing price 06/23/2026 04:00 PM Eastern

Extended Trading

$9.81 +0.11 (+1.13%)

As of 06/23/2026 07:59 PM Eastern

Compare

AHCO vs. CAI, BLLN, SHC, RDNT, and CELC

Should you buy AdaptHealth stock or one of its competitors? MarketBeat compares AdaptHealth with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with AdaptHealth include Caris Life Sciences (CAI), Billiontoone (BLLN), Sotera Health (SHC), RadNet (RDNT), and Celcuity (CELC). These companies are all part of the "healthcare" industry.

How does AdaptHealth compare to Caris Life Sciences?

AdaptHealth (NASDAQ:AHCO) and Caris Life Sciences (NASDAQ:CAI) are both healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their media sentiment, dividends, analyst recommendations, earnings, institutional ownership, profitability, valuation and risk.

AdaptHealth currently has a consensus target price of $14.29, suggesting a potential upside of 47.28%. Caris Life Sciences has a consensus target price of $27.56, suggesting a potential upside of 56.57%. Given Caris Life Sciences' higher probable upside, analysts clearly believe Caris Life Sciences is more favorable than AdaptHealth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AdaptHealth	1 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.50
Caris Life Sciences	1 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.45

82.7% of AdaptHealth shares are held by institutional investors. 2.0% of AdaptHealth shares are held by insiders. Comparatively, 50.0% of Caris Life Sciences shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Caris Life Sciences had 2 more articles in the media than AdaptHealth. MarketBeat recorded 3 mentions for Caris Life Sciences and 1 mentions for AdaptHealth. AdaptHealth's average media sentiment score of 0.67 beat Caris Life Sciences' score of 0.38 indicating that AdaptHealth is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
AdaptHealth	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Caris Life Sciences	0 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Caris Life Sciences has a net margin of 3.75% compared to AdaptHealth's net margin of -2.42%. Caris Life Sciences' return on equity of 98.28% beat AdaptHealth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AdaptHealth	-2.42%	2.76%	0.99%
Caris Life Sciences	3.75%	98.28%	48.87%

Caris Life Sciences has lower revenue, but higher earnings than AdaptHealth. AdaptHealth is trading at a lower price-to-earnings ratio than Caris Life Sciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AdaptHealth	$3.24B	0.41	-$70.79M	-$0.62	N/A
Caris Life Sciences	$812.03M	6.13	-$68.09M	-$7.61	N/A

Summary

Caris Life Sciences beats AdaptHealth on 10 of the 15 factors compared between the two stocks.

How does AdaptHealth compare to Billiontoone?

Billiontoone (NASDAQ:BLLN) and AdaptHealth (NASDAQ:AHCO) are both healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, analyst recommendations, media sentiment, risk, earnings, valuation, institutional ownership and dividends.

82.7% of AdaptHealth shares are held by institutional investors. 2.0% of AdaptHealth shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

In the previous week, Billiontoone had 5 more articles in the media than AdaptHealth. MarketBeat recorded 6 mentions for Billiontoone and 1 mentions for AdaptHealth. AdaptHealth's average media sentiment score of 0.67 beat Billiontoone's score of -0.18 indicating that AdaptHealth is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Billiontoone	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
AdaptHealth	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Billiontoone has a net margin of 0.00% compared to AdaptHealth's net margin of -2.42%. AdaptHealth's return on equity of 2.76% beat Billiontoone's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Billiontoone	N/A	N/A	N/A
AdaptHealth	-2.42%	2.76%	0.99%

Billiontoone currently has a consensus price target of $125.29, indicating a potential upside of 20.14%. AdaptHealth has a consensus price target of $14.29, indicating a potential upside of 47.28%. Given AdaptHealth's higher possible upside, analysts plainly believe AdaptHealth is more favorable than Billiontoone.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Billiontoone	1 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.50
AdaptHealth	1 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.50

Billiontoone has higher earnings, but lower revenue than AdaptHealth. AdaptHealth is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Billiontoone	$305.11M	15.72	$7.45M	$0.55	189.60
AdaptHealth	$3.24B	0.41	-$70.79M	-$0.62	N/A

Summary

Billiontoone and AdaptHealth tied by winning 7 of the 14 factors compared between the two stocks.

How does AdaptHealth compare to Sotera Health?

AdaptHealth (NASDAQ:AHCO) and Sotera Health (NASDAQ:SHC) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, risk, institutional ownership, profitability, earnings, media sentiment, dividends and valuation.

AdaptHealth has a beta of 1.47, suggesting that its stock price is 47% more volatile than the broader market. Comparatively, Sotera Health has a beta of 1.79, suggesting that its stock price is 79% more volatile than the broader market.

AdaptHealth presently has a consensus target price of $14.29, suggesting a potential upside of 47.28%. Sotera Health has a consensus target price of $20.29, suggesting a potential upside of 28.07%. Given AdaptHealth's higher probable upside, equities research analysts plainly believe AdaptHealth is more favorable than Sotera Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AdaptHealth	1 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.50
Sotera Health	0 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.73

Sotera Health has lower revenue, but higher earnings than AdaptHealth. AdaptHealth is trading at a lower price-to-earnings ratio than Sotera Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AdaptHealth	$3.24B	0.41	-$70.79M	-$0.62	N/A
Sotera Health	$1.19B	3.80	$77.94M	$0.41	38.63

In the previous week, AdaptHealth had 1 more articles in the media than Sotera Health. MarketBeat recorded 1 mentions for AdaptHealth and 0 mentions for Sotera Health. AdaptHealth's average media sentiment score of 0.67 beat Sotera Health's score of 0.00 indicating that AdaptHealth is being referred to more favorably in the media.

Company	Overall Sentiment
AdaptHealth	Positive
Sotera Health	Neutral

Sotera Health has a net margin of 9.91% compared to AdaptHealth's net margin of -2.42%. Sotera Health's return on equity of 39.73% beat AdaptHealth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AdaptHealth	-2.42%	2.76%	0.99%
Sotera Health	9.91%	39.73%	7.05%

82.7% of AdaptHealth shares are owned by institutional investors. Comparatively, 91.0% of Sotera Health shares are owned by institutional investors. 2.0% of AdaptHealth shares are owned by insiders. Comparatively, 15.4% of Sotera Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Summary

Sotera Health beats AdaptHealth on 12 of the 16 factors compared between the two stocks.

How does AdaptHealth compare to RadNet?

RadNet (NASDAQ:RDNT) and AdaptHealth (NASDAQ:AHCO) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, dividends, analyst recommendations, risk, institutional ownership, earnings, media sentiment and valuation.

In the previous week, RadNet had 6 more articles in the media than AdaptHealth. MarketBeat recorded 7 mentions for RadNet and 1 mentions for AdaptHealth. AdaptHealth's average media sentiment score of 0.67 beat RadNet's score of 0.04 indicating that AdaptHealth is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
RadNet	2 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
AdaptHealth	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

RadNet presently has a consensus price target of $87.43, suggesting a potential upside of 55.57%. AdaptHealth has a consensus price target of $14.29, suggesting a potential upside of 47.28%. Given RadNet's stronger consensus rating and higher probable upside, equities research analysts clearly believe RadNet is more favorable than AdaptHealth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
RadNet	1 Sell rating(s)	1 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	2.90
AdaptHealth	1 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.50

RadNet has a beta of 1.41, indicating that its share price is 41% more volatile than the broader market. Comparatively, AdaptHealth has a beta of 1.47, indicating that its share price is 47% more volatile than the broader market.

77.9% of RadNet shares are held by institutional investors. Comparatively, 82.7% of AdaptHealth shares are held by institutional investors. 5.6% of RadNet shares are held by insiders. Comparatively, 2.0% of AdaptHealth shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

RadNet has a net margin of -0.66% compared to AdaptHealth's net margin of -2.42%. RadNet's return on equity of 2.77% beat AdaptHealth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
RadNet	-0.66%	2.77%	0.97%
AdaptHealth	-2.42%	2.76%	0.99%

RadNet has higher earnings, but lower revenue than AdaptHealth. RadNet is trading at a lower price-to-earnings ratio than AdaptHealth, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
RadNet	$2.04B	2.17	-$18.65M	-$0.18	N/A
AdaptHealth	$3.24B	0.41	-$70.79M	-$0.62	N/A

Summary

RadNet beats AdaptHealth on 11 of the 17 factors compared between the two stocks.

How does AdaptHealth compare to Celcuity?

Celcuity (NASDAQ:CELC) and AdaptHealth (NASDAQ:AHCO) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, media sentiment, earnings, profitability, valuation, analyst recommendations, institutional ownership and risk.

Celcuity has a beta of 0.1, suggesting that its stock price is 90% less volatile than the broader market. Comparatively, AdaptHealth has a beta of 1.47, suggesting that its stock price is 47% more volatile than the broader market.

Celcuity has a net margin of 0.00% compared to AdaptHealth's net margin of -2.42%. AdaptHealth's return on equity of 2.76% beat Celcuity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Celcuity	N/A	-244.61%	-50.22%
AdaptHealth	-2.42%	2.76%	0.99%

63.3% of Celcuity shares are owned by institutional investors. Comparatively, 82.7% of AdaptHealth shares are owned by institutional investors. 13.3% of Celcuity shares are owned by company insiders. Comparatively, 2.0% of AdaptHealth shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

AdaptHealth has higher revenue and earnings than Celcuity. Celcuity is trading at a lower price-to-earnings ratio than AdaptHealth, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Celcuity	N/A	N/A	-$177.04M	-$3.90	N/A
AdaptHealth	$3.24B	0.41	-$70.79M	-$0.62	N/A

Celcuity presently has a consensus target price of $152.09, indicating a potential upside of 68.60%. AdaptHealth has a consensus target price of $14.29, indicating a potential upside of 47.28%. Given Celcuity's stronger consensus rating and higher probable upside, analysts plainly believe Celcuity is more favorable than AdaptHealth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Celcuity	1 Sell rating(s)	0 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.83
AdaptHealth	1 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.50

In the previous week, Celcuity had 4 more articles in the media than AdaptHealth. MarketBeat recorded 5 mentions for Celcuity and 1 mentions for AdaptHealth. Celcuity's average media sentiment score of 1.74 beat AdaptHealth's score of 0.67 indicating that Celcuity is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Celcuity	5 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
AdaptHealth	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

AdaptHealth beats Celcuity on 8 of the 15 factors compared between the two stocks.

Get AdaptHealth News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AHCO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

AHCO vs. The Competition

Export

Metric	AdaptHealth	MED PRODUCTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$1.31B	$8.08B	$6.45B	$12.39B
Dividend Yield	N/A	2.60%	2.69%	5.83%
P/E Ratio	-15.64	15.24	24.92	23.98
Price / Sales	0.41	6.98	528.23	109.07
Price / Cash	2.31	16.83	44.82	54.51
Price / Book	0.86	3.21	10.79	6.50
Net Income	-$70.79M	$226.25M	$3.56B	$336.88M
7 Day Performance	1.78%	-1.89%	1.00%	-0.14%
1 Month Performance	-7.18%	-3.72%	0.42%	0.77%
1 Year Performance	10.73%	-1.12%	29.70%	28.49%

AdaptHealth Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
AHCO AdaptHealth	4.5879 of 5 stars	$9.70 +0.4%	$14.29 +47.3%	+16.9%	$1.31B	$3.24B	N/A	10,900
CAI Caris Life Sciences	4.4035 of 5 stars	$18.18 +1.2%	$27.56 +51.6%	N/A	$5.08B	$812.03M	N/A	1,846
BLLN Billiontoone	3.4062 of 5 stars	$103.95 +2.8%	$125.29 +20.5%	N/A	$4.65B	$305.11M	189.00	620
SHC Sotera Health	4.0079 of 5 stars	$16.23 +0.2%	$20.29 +25.0%	+42.8%	$4.62B	$1.16B	39.59	3,000
RDNT RadNet	2.7047 of 5 stars	$57.05 +0.6%	$87.43 +53.2%	+2.4%	$4.46B	$2.04B	N/A	11,264	Insider Trade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:AHCO) was last updated on 6/24/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

AdaptHealth (AHCO) Competitors

AHCO vs. CAI, BLLN, SHC, RDNT, and CELC

How does AdaptHealth compare to Caris Life Sciences?

Summary

How does AdaptHealth compare to Billiontoone?

Summary

How does AdaptHealth compare to Sotera Health?

Summary

How does AdaptHealth compare to RadNet?

Summary

How does AdaptHealth compare to Celcuity?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AHCO vs. The Competition

AdaptHealth Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

AdaptHealth (AHCO) Competitors

AHCO vs. CAI, BLLN, SHC, RDNT, and CELC

How does AdaptHealth compare to Caris Life Sciences?

Do analysts rate AHCO or CAI?

Do institutionals and insiders have more ownership in AHCO or CAI?

Does the media refer more to AHCO or CAI?

Is AHCO or CAI more profitable?

Which has stronger valuation & earnings, AHCO or CAI?

Summary

How does AdaptHealth compare to Billiontoone?

Do institutionals & insiders believe in BLLN or AHCO?

Does the media favor BLLN or AHCO?

Is BLLN or AHCO more profitable?

Do analysts rate BLLN or AHCO?

Which has stronger valuation & earnings, BLLN or AHCO?

Summary

How does AdaptHealth compare to Sotera Health?

Which has more risk & volatility, AHCO or SHC?

Do analysts prefer AHCO or SHC?

Which has higher valuation & earnings, AHCO or SHC?

Does the media favor AHCO or SHC?

Is AHCO or SHC more profitable?

Do institutionals and insiders have more ownership in AHCO or SHC?

Summary

How does AdaptHealth compare to RadNet?

Does the media prefer RDNT or AHCO?

Do analysts recommend RDNT or AHCO?

Which has more risk and volatility, RDNT or AHCO?

Do institutionals and insiders have more ownership in RDNT or AHCO?

Is RDNT or AHCO more profitable?

Which has higher earnings and valuation, RDNT or AHCO?

Summary

How does AdaptHealth compare to Celcuity?

Which has more volatility & risk, CELC or AHCO?

Is CELC or AHCO more profitable?

Do institutionals and insiders believe in CELC or AHCO?

Which has better valuation and earnings, CELC or AHCO?

Do analysts recommend CELC or AHCO?

Does the media prefer CELC or AHCO?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AHCO vs. The Competition

AdaptHealth Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools